FIELD: medicine.
SUBSTANCE: invention refers to medicine and chemical-pharmaceutical industry. Trimetazidine preparation as a matrix tablet of prolonged action contains an active substance, montanic glycolic wax, polymer of methacrylic acid, hydrophilic polymer representing hydroxypropyl methylcellulose, microcrystalline cellulose, mannitol and adjuvants, in amounts specified in the patent claim. There is also disclosed method for making Trimetazidine preparation as a matrix tablet.
EFFECT: invention provides controlled prolonged release of Trimetazidine that leads to stable concentration level of the active substance.
10 cl, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONTROLLED RELEASE TRIMETAZIDINE MATRIX TABLET | 2006 |
|
RU2367438C2 |
| METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
| CRYSTAL STRUCTURE OF MEDICATION IN TABLET FORM (VERSIONS) | 2009 |
|
RU2420286C2 |
| MODIFIED RELEASE DOSAGE FORM OF TRIMETHAZIDIN AND METHOD FOR PREPARING THEREOF (VERSIONS) | 2008 |
|
RU2410097C2 |
| PROLONGED PHARMACEUTICAL COMPOSITION DRUG FORM AND METHOD OF ITS PRODUCTION (VERSIONS) | 2009 |
|
RU2435584C2 |
| MODIFIED RELEASE DOSAGE FORM OF TRIMETAZIDINE DIHYDROCHLORIDE | 2009 |
|
RU2412706C1 |
| PHARMACEUTICAL COMPOSITIONS WITH PROLONGED RELEASE FOR TREATING CEREBROVASCULAR DISORDERS | 2014 |
|
RU2611339C2 |
| PROLONGED ACTION PHARMACEUTICAL COMPOSITION BASED ON 5-ETHOXY-2-[2-(MORPHOLINO)-ETHYLTHIO]BENZIMIDAZOLE DIHYDROCHLORIDE AND/OR BASE (APHOBAZOLUM) | 2017 |
|
RU2694837C2 |
| RANOLAZINE PREPARATIONS WITH PROLONGED EFFECT | 1999 |
|
RU2214233C2 |
| MATRIX TABLET WITH TRIMETAZIDINE PROLONGED-RELEASE BASE AND METHOD FOR PREPARING IT | 2010 |
|
RU2445958C2 |
